表皮生長(zhǎng)因子(EGF)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法)
CLIA Kit for Epidermal Growth Factor (EGF)
URG; Beta-Urogastrone; Pro-epidermal growth factor
- 編號(hào)USCA560Ra
 - 物種Rattus norvegicus (Rat,大鼠) 相同的名稱,不同的物種。
 - 實(shí)驗(yàn)方法雙抗夾心
 - 反應(yīng)時(shí)長(zhǎng)2h, 40min
 - 檢測(cè)范圍2.74-2,000pg/mL
 - 靈敏度最小可檢測(cè)劑量小于等于0.94pg/mL.
 - 樣本類型Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
 - 下載 英文說明書 中文說明書
 - 規(guī)格 48T96T 96T*5 96T*10 96T*100
 - 價(jià)格 ¥ 1915 ¥ 2736 ¥ 12312 ¥ 23256 ¥ 191520
 - 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
特異性
                        本試劑盒用于檢測(cè)表皮生長(zhǎng)因子(EGF),經(jīng)檢測(cè)與其它相似物質(zhì)無明顯交叉反應(yīng)。
                        由于受到技術(shù)及樣本來源的限制,不可能完成對(duì)所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測(cè),因此本試劑盒有可能與未經(jīng)檢測(cè)的其它物質(zhì)有交叉反應(yīng)。
                    
回收率
分別于定值血清及血漿樣本中加入一定量的表皮生長(zhǎng)因子(EGF)(加標(biāo)樣品),重復(fù)測(cè)定并計(jì)算其均值,回收率為測(cè)定值與理論值的比率。
| 樣本 | 回收率范圍(%) | 平均回收率(%) | 
| serum(n=5) | 80-93 | 85 | 
| EDTA plasma(n=5) | 96-103 | 101 | 
| heparin plasma(n=5) | 80-105 | 92 | 
精密度
                    精密度用樣品測(cè)定值的變異系數(shù)CV表示。CV(%) = SD/mean×100 
                    批內(nèi)差:取同批次試劑盒對(duì)低、中、高值定值樣本進(jìn)行定量檢測(cè),每份樣本連續(xù)測(cè)定20 次,分別計(jì)算不同濃度樣本的平均值及SD值。
                    批間差:選取3個(gè)不同批次的試劑盒分別對(duì)低、中、高值定值樣本進(jìn)行定量測(cè)定,每個(gè)樣本使用同一試劑盒重復(fù)測(cè)定8次,分別計(jì)算不同濃度樣本的平均值及SD值。
                    批內(nèi)差: CV<10% 
                    批間差: CV<12% 
                
線性
在定值血清及血漿樣本內(nèi)加入適量的表皮生長(zhǎng)因子(EGF),并倍比稀釋成1:2,1:4,1:8,1:16的待測(cè)樣本,線性范圍即為稀釋后樣本中表皮生長(zhǎng)因子(EGF)含量的測(cè)定值與理論值的比率。
| 樣本 | 1:2 | 1:4 | 1:8 | 1:16 | 
| serum(n=5) | 96-105% | 97-104% | 97-104% | 95-105% | 
| EDTA plasma(n=5) | 88-95% | 95-102% | 80-104% | 94-105% | 
| heparin plasma(n=5) | 89-96% | 94-105% | 83-93% | 88-101% | 
穩(wěn)定性
                    經(jīng)測(cè)定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
                    為減小外部因素對(duì)試劑盒破壞前后檢測(cè)值的影響,實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致,尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來進(jìn)行操作可減少人為誤差。
                
實(shí)驗(yàn)流程
                    1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備;
                            2. 加樣(標(biāo)準(zhǔn)品及樣本)100µL,37°C孵育1小時(shí);
                            3. 吸棄,加檢測(cè)溶液A100μL,37°C孵育1小時(shí);
                            4. 洗板3次;
                            5. 加檢測(cè)溶液B100µL,37°C孵育30分鐘;
                            6. 洗板5次;
                            7. 加底物100µL,37°C孵育10分鐘;
                            8. 讀數(shù)。
                
實(shí)驗(yàn)原理
將表皮生長(zhǎng)因子(EGF)抗體包被于96孔微孔板中,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本,其中的表皮生長(zhǎng)因子(EGF)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的表皮生長(zhǎng)因子(EGF)抗體,將未結(jié)合的生物素化抗體洗凈后,加入HRP標(biāo)記的親和素,再次徹底洗滌后加入底物。加入底物后會(huì)產(chǎn)生輝光型光信號(hào)。發(fā)射光強(qiáng)度和樣品中的表皮生長(zhǎng)因子(EGF)呈正相關(guān)。用化學(xué)發(fā)光儀測(cè)定相對(duì)光單位(RLU),計(jì)算樣品濃度。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Rattus norvegicus (Rat,大鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| UAPA560Ra61 | 表皮生長(zhǎng)因子(EGF)活性蛋白 | Cell?culture;?Activity?Assays. | 
| UEPA560Ra61 | 表皮生長(zhǎng)因子(EGF)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UAPA560Ra01 | 表皮生長(zhǎng)因子(EGF)活性蛋白 | Cell?culture;?Activity?Assays. | 
| URPA560Ra01 | 表皮生長(zhǎng)因子(EGF)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UPAA560Ra01 | 表皮生長(zhǎng)因子(EGF)多克隆抗體 | WB | 
| UMAA560Ra22 | 表皮生長(zhǎng)因子(EGF)單克隆抗體 | IHC | 
| UMAA560Ra23 | 表皮生長(zhǎng)因子(EGF)單克隆抗體 | IHC | 
| UMAA560Ra25 | 表皮生長(zhǎng)因子(EGF)單克隆抗體 | IHC | 
| UMAA560Ra27 | 表皮生長(zhǎng)因子(EGF)單克隆抗體 | IHC | 
| UMAA560Ra24 | 表皮生長(zhǎng)因子(EGF)單克隆抗體 | WB; IHC | 
| UMAA560Ra21 | 表皮生長(zhǎng)因子(EGF)單克隆抗體 | WB; IHC | 
| ULAA560Ra72 | 表皮生長(zhǎng)因子(EGF)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. | 
| USEA560Ra | 表皮生長(zhǎng)因子(EGF)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| USCA560Ra | 表皮生長(zhǎng)因子(EGF)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. | 
| ULMA560Ra | 表皮生長(zhǎng)因子(EGF)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
| UPSA560Ra01 | 表皮生長(zhǎng)因子(EGF)抗體對(duì) | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. | 
| UKSA560Ra01 | 表皮生長(zhǎng)因子(EGF)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Journal of Pediatric Surgery | The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model [PubMed: 20438940] | 
| Biomark Insights | Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism [PubMed: PMC3623607] | 
| Plos one | The Probiotic Mixture VSL#3 Accelerates Gastric Ulcer Healing by Stimulating Vascular Endothelial Growth Factor [PubMed: PMC3590171] | 
| Diabetes. | Allogeneic transplantation of an adipose-derived stem cell (ASC) sheet combined with artificial skin accelerates wound healing in a rat wound model of type 2 diabetes and obesity [Pubmed:25795216] | 
| Eur Rev Med Pharmacol Sci.? | Association of colon adenomas and skin tags: coincidence or coexistence? [Pubmed:24763889] | 
| Int J Clin Exp Med. | The effects of self-assembling peptide RADA16 hydrogel on malignant phenotype of human hepatocellular carcinoma cell [PubMed: 26628972] | 
| ACS Applied Materials & Interfaces | Polydopamine nanoparticles modulating stimuli-responsive PNIPAM hydrogels with cell/tissue adhesiveness. [pubmed:27709887] | 
| Canadian Journal of Physiology and Pharmacology | The effect of midkine on growth factors and oxidative status in an experimental wound model in diabetic and healthy rats [pubmed:28177680] | 
| Journal of Controlled Release | A DPP-IV-resistant glucagon-like peptide-2 dimer with enhanced activity against radiation-induced intestinal injury [pubmed:28522195] | 
| Scientific Reports | Optimization of Storage Temperature for Retention of Undifferentiated Cell Character of Cultured Human Epidermal Cell Sheets [pubmed:28811665] | 
| International Journal of?Nanomedicine | Micro-/nano-topography of selective laser melting titanium enhances adhesion and proliferation and regulates adhesion-related gene expressions of human?… [Pubmed: 30233172] | 
| Neoplasia | Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine [Pubmed: 33212364] | 
| Aesthet Surg J | Adipose-Derived Stem Cells Improve the Aging Skin of Nude Mice by Promoting Angiogenesis and Reducing Local Tissue Water [33428732] | 
| Cell Death & Disease | Sodium/glucose cotransporter 1-dependent metabolic alterations induce tamoxifen resistance in breast cancer by promoting macrophage M2 polarization [34006822] | 
| Stem Cells International | The Paracrine Effect of Adipose-Derived Stem Cells Orchestrates Competition between Different Damaged Dermal Fibroblasts to Repair UVB-Induced Skin??- [33381190] | 
| Molecular Biology Reports | Umbilical cord-derived mesenchymal stem cell conditioned medium reverses neuronal oxidative injury by inhibition of TRPM2 activation and the JNK signaling?… [Pubmed:35585377] | 
| Biomaterials Advances | Human adipose-derived stem cell-loaded small intestinal submucosa as a bioactive wound dressing for the treatment of diabetic wounds in rats [] | 
| Authorea | Syringaresinol attenuates kidney injury by inhibition of pyroptosis via activating the Nrf2 antioxidant pathway in diabetic nephropathy [] | 
| Biointerface Research in Applied Chemistry | Beetroot Improves the Therapeutic Efficacy of Bone Marrow-Derived Mesenchymal Stem Cells in Preventing Cisplatin Induced Nephrotoxicity in Male Rats [] | 

                    
                    
                                    